---
title: Functional, Dynamic, and Anatomic MR Urography
nct_id: NCT00585767
overall_status: WITHDRAWN
sponsor: University of California, Davis
study_type: OBSERVATIONAL
primary_condition: Hydronephrosis
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00585767.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00585767"
ct_last_update_post_date: 2017-05-30
last_seen_at: "2026-05-12T06:31:59.214Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Functional, Dynamic, and Anatomic MR Urography

**NCT ID:** [NCT00585767](https://clinicaltrials.gov/study/NCT00585767)

## Key Facts

- **Status:** WITHDRAWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 0
- **Lead Sponsor:** University of California, Davis
- **Conditions:** Hydronephrosis
- **Start Date:** 2001-04
- **Completion Date:** 2013-05
- **CT.gov Last Update:** 2017-05-30

## Brief Summary

This is a clinical feasibility study to assess the value of MR imaging for obtaining functional, dynamic and anatomical information in a comprehensive imaging protocol in subjects having obstructive uropathy.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Males or females 18 years of age or older.
* All female patients of childbearing potential must agree to use a medically accepted method of contraception at the time of the study.
* Patients must have the ability to understand the requirements of the study, provide written and informed consent to participate, and agree to abide by the study requirements.
* Patients who have known or suspected hydronephrosis or patients with solitary kidneys.

Exclusion Criteria:

* Patients with known or suspected hypersensitivity to gadolinium-based agents.
* Patients who are pregnant or lactating.
* Patients with a condition that is a contraindication to MRI (e.g., cardiac pacemaker, epicardial pacemaker leads, cochlear implants, ferromagnetic aneurysm clip, ferromagnetic halo device, or other conditions that would preclude patient proximity to a strong external magnetic field).
* Patients with a recent history of hemolytic anemia, sickle cell anemia or other hemoglobinopathy.
* Patients with a history of significant claustrophobia.
* Patients with impaired renal function based on 24-hr urine collection (creatinine clearance \<10 ml/min or serum creatinine \>1.8 mg/dl)
```

## Arms

- **1** — Patients with two kidneys
- **2** — Patients with solitary kidney

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00585767.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00585767*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*